By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntegenX today announced it has raised $40 million in a Series C financing round for the further development of its product pipeline and commercialization of its RapidHIT 200 Human Identification System.

Leading the round was new investor Essex Woodlands, a healthcare growth equity and venture capital firm. Existing investors Domain Associates, QuestMark Partners, Greenspring Associates, Cross Creek Capital, RONAholdings, Samsung Ventures, and strategic partner In-Q-Tel also participated in the round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.